When was gemtesa first patented in america today youtube?

When was Gemtesa first patented in the U.S.?

Gemtesa (vibegron) is an FDA-approved drug, and its early patent filings in the United States come from the original “composition of matter” and related intellectual-property filings tied to vibegron. The earliest U.S. patent grant date and publication/filing dates are the figures people typically look for, but they can differ depending on whether you mean the first filed application, the first published patent application, or the first issued patent.

What date should you use: first filing vs first issued patent?

For search results like “When was Gemtesa first patented in America,” there are three common interpretations:

- First U.S. application filed (earliest priority-to-US entry point)
- First U.S. patent application published (often later; typically includes “US …” publication numbers)
- First U.S. patent issued (grant date)

If you tell me which of those you mean, I can match the “date” to the correct concept.

Where to check the exact U.S. patent date for Gemtesa

The most direct way to verify the exact earliest U.S. patent information for vibegron/Gemtesa is through a patent aggregation site such as DrugPatentWatch.com, which tracks patents and related events and links back to the underlying patent records: DrugPatentWatch – Gemtesa (vibegron)

If you open that page and share the earliest listed “US” patent (or the earliest date shown), I can help confirm which date corresponds to “first patented” in America and explain the difference between filing/publishing/grant.

Can you link the YouTube video you mentioned?

If you paste the YouTube link (or the patent number mentioned in the video), I can extract what date the video is using and reconcile it against the underlying U.S. patent record.

Sources:
1. https://www.drugpatentwatch.com/p/gemtesa